Low Potassium Dialysate Improves Hyperkalemia In ESRD Patients
- byDoctor News Daily Team
- 13 July, 2025
- 0 Comments
- 0 Mins
Hyperkalemia is a modifiable risk factor for sudden cardiac death, a leading cause of mortality in hemodialysis patients. A study published in the Clinical Kidney Journal on December 17, 2020, suggests that a low potassium bath for the treatment of severe hyperkalemia (>6.5 mmol/L) in hospitalized end-stage renal disease (ESRD) patients are associated with decreased in-hospital mortality or cardiac arrest.
Pre-dialysis hyperkalemia is associated with higher mortality in ESRD patients on maintenance hemodialysis (HD) in the outpatient setting. The optimal treatment of hyperkalemia in hospitalized ESRD patients is nonexistent in literature which has prompted studies from outpatient dialysis to be extrapolated to inpatient care. Therefore, researchers of the University of Wisconsin School of Medicine and Public Health, USA, conducted a study to determine whether low potassium dialysate 1 meq/L is associated with higher mortality in hospitalized ESRD patients with severe hyperkalemia (serum potassium > 6.5 mmol/L).
It was a retrospective study of all adult ESRD patients admitted with severe hyperkalemia between January 2011- August 2016. The researchers included a total of 209 ESRD patients with severe hyperkalemia during the study period. The major outcome assessed was in-hospital death or cardiac arrest. Most patients received the 1 mEq/L potassium bath during the first hour of dialysis, then transitioned to higher potassium baths.
Key findings of the study were:
Upon analysis, the researchers found that In-hospital mortality or cardiac arrest in ESRD patients with severe hyperkalemia was 12.4%.
They noted that the median time to dialysis after serum potassium result was 2.0 hours (25, 75 IQR 0.9, 4.2 hours).
They found that the use of 1mEq/L potassium bath was associated with significantly lower mortality or cardiac arrest in ESRD patients admitted with severe hyperkalemia (OR 0.27).
The authors concluded, "Use of 1K dialysis bath in hospitalized ESRD patients with severe hyperkalemia was associated with significantly lower risk of death or cardiac arrest compared to higher potassium dialysis bath."
For further information:
DOI: https://doi.org/10.1093/ckj/sfaa263
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
DME Gujarat extends PG Ayurveda, Homeopathy round...
- 05 November, 2025
NEET counselling: CENTAC publishes round 3 provisi...
- 05 November, 2025
Marksans Pharma UK arm gets marketing nod for Exem...
- 05 November, 2025
Zydus Wellness net sales up by 31 percent in Q2 FY...
- 05 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!